Gillian M. Lamont

1.6k total citations
15 papers, 243 citations indexed

About

Gillian M. Lamont is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Gillian M. Lamont has authored 15 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Gillian M. Lamont's work include DNA Repair Mechanisms (3 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Gillian M. Lamont is often cited by papers focused on DNA Repair Mechanisms (3 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Gillian M. Lamont collaborates with scholars based in United Kingdom, Germany and Poland. Gillian M. Lamont's co-authors include Frederick W. Goldberg, David T. Beattie, Attilla Ting, M. Raymond V. Finlay, Elaine Cadogan, Barry R. Davies, Susan E. Critchlow, Mercedes Vázquez–Chantada, Beth Williamson and Antonio Ramos‐Montoya and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Gillian M. Lamont

15 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian M. Lamont United Kingdom 8 156 75 58 35 29 15 243
Takaharu Hirayama Japan 8 186 1.2× 115 1.5× 82 1.4× 33 0.9× 31 1.1× 9 356
Ryan Stansfield United States 8 281 1.8× 60 0.8× 53 0.9× 26 0.7× 15 0.5× 11 355
Chon Lai United States 6 286 1.8× 57 0.8× 72 1.2× 29 0.8× 23 0.8× 10 364
Kin‐Chun Luk United States 10 202 1.3× 125 1.7× 113 1.9× 30 0.9× 16 0.6× 15 342
Lijiao Wang China 10 157 1.0× 97 1.3× 67 1.2× 27 0.8× 12 0.4× 24 334
Michael Burkard United States 10 164 1.1× 59 0.8× 58 1.0× 17 0.5× 14 0.5× 19 268
Isao Yasumatsu Japan 9 206 1.3× 60 0.8× 38 0.7× 37 1.1× 12 0.4× 17 271
Yuandi Gao Canada 8 181 1.2× 31 0.4× 57 1.0× 34 1.0× 45 1.6× 12 280
Vineet Kumar United States 7 198 1.3× 55 0.7× 31 0.5× 32 0.9× 13 0.4× 12 306
Susanna Stinson United States 3 175 1.1× 45 0.6× 114 2.0× 24 0.7× 11 0.4× 4 265

Countries citing papers authored by Gillian M. Lamont

Since Specialization
Citations

This map shows the geographic impact of Gillian M. Lamont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian M. Lamont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian M. Lamont more than expected).

Fields of papers citing papers by Gillian M. Lamont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian M. Lamont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian M. Lamont. The network helps show where Gillian M. Lamont may publish in the future.

Co-authorship network of co-authors of Gillian M. Lamont

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian M. Lamont. A scholar is included among the top collaborators of Gillian M. Lamont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian M. Lamont. Gillian M. Lamont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bagal, Sharan K., Peter C. Astles, C. R. Diène, et al.. (2024). Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer. Journal of Medicinal Chemistry. 67(14). 11732–11750. 5 indexed citations
2.
Clark, Roger, Ronald Tomlinson, Andrea M. Zuhl, et al.. (2023). Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS Chemical Biology. 18(2). 296–303. 8 indexed citations
3.
Goldberg, Frederick W., Attilla Ting, David T. Beattie, et al.. (2022). Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK. ACS Medicinal Chemistry Letters. 13(8). 1295–1301. 7 indexed citations
4.
Goldberg, Frederick W., Jason G. Kettle, Gillian M. Lamont, et al.. (2022). Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. Journal of Medicinal Chemistry. 66(1). 384–397. 38 indexed citations
5.
Goldberg, Frederick W., M. Raymond V. Finlay, Attilla Ting, et al.. (2019). The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. Journal of Medicinal Chemistry. 63(7). 3461–3471. 66 indexed citations
6.
Goldberg, Frederick W., Elaine Cadogan, David A. Beattie, et al.. (2019). Abstract DDT01-02: Discovery and first structural disclosure of AZD7648: A potent and selective DNA-PK inhibitor. DDT01–2. 1 indexed citations
7.
Goldberg, Frederick W., Elaine Cadogan, David T. Beattie, et al.. (2019). Abstract DDT01-02: Discovery and first structural disclosure of AZD7648: A potent and selective DNA-PK inhibitor. Cancer Research. 79(13_Supplement). DDT01–2. 1 indexed citations
8.
McCoull, William, Edward J. Hennessy, Kevin Blades, et al.. (2016). Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. ACS Medicinal Chemistry Letters. 7(12). 1118–1123. 20 indexed citations
9.
Degorce, Sébastien L., Andrew Bailey, Rowena Callis, et al.. (2015). Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators. Journal of Medicinal Chemistry. 58(8). 3522–3533. 37 indexed citations
10.
McCoull, William, Edward J. Hennessy, Kevin Blades, et al.. (2014). Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity. MedChemComm. 5(10). 1533–1539. 14 indexed citations
11.
Blades, Kevin, et al.. (2014). Synthesis of the Novel Tetrahydropyrazolo[3,4-c]pyridin-5-one Scaffold. Synlett. 26(2). 228–232. 2 indexed citations
12.
Kemmitt, Paul D., Kevin Blades, Matthew Box, et al.. (2014). Synthesis of 3-(Hetero)aryl Tetrahydropyrazolo[3,4-c]pyridines by Suzuki–Miyaura Cross-Coupling Methodology. The Journal of Organic Chemistry. 79(16). 7682–7688. 1 indexed citations
13.
14.
Finlay, M. Raymond V., David Buttar, Susan E. Critchlow, et al.. (2012). Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 22(12). 4163–4168. 27 indexed citations
15.
Bethel, Paul A., Andrew D. Campbell, Frederick W. Goldberg, et al.. (2012). Optimized scale up of 3-pyrimidinylpyrazolo[1,5-a]pyridine via Suzuki coupling; a general method of accessing a range of 3-(hetero)arylpyrazolo[1,5-a]pyridines. Tetrahedron. 68(27-28). 5434–5444. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takaharu Hirayama Breakdown of academic impact, for papers by Ryan Stansfield Breakdown of academic impact, for papers by Chon Lai Breakdown of academic impact, for papers by Kin‐Chun Luk Breakdown of academic impact, for papers by Lijiao Wang Breakdown of academic impact, for papers by Michael Burkard Breakdown of academic impact, for papers by Isao Yasumatsu Breakdown of academic impact, for papers by Yuandi Gao Breakdown of academic impact, for papers by Vineet Kumar Breakdown of academic impact, for papers by Susanna Stinson
Rankless by CCL
2026